AHCO Stock Recent News

One of the pharmaceutical giant's hotter medications tested well for a new indication. It has already attracted much attention for the molecule being studied, as it's used in two FDA-approved treatments already.

Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?

Here is how AdaptHealth Corp. (AHCO) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Investors looking for stocks in the Medical - Products sector might want to consider either AdaptHealth Corp. (AHCO) or Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?

Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.

They may not be household names like Meta Platforms Inc. NASDAQ: META or investor favorites like Nvidia Corp. NASDAQ: NVDA, but several small stocks, such as Ultra Clean Holdings, Inc. NASDAQ: UCTT, Powell Industries Inc. NASDAQ: POWL and AdaptHealth Corp. NASDAQ: AHCO are outperforming major indexes.

Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?

Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.

AdaptHealth Corp. (AHCO) Q4 2023 Earnings Call Transcript

AdaptHealth badly missed analysts' consensus earnings estimate for the fourth quarter, but beat their revenue estimate. The earnings miss was due entirely to a goodwill write-down.